Ncole Pharmaceuticals Private Limited
About Ncole Pharmaceuticals Private Limited
Data last updated:
Ncole Pharmaceuticals Private Limited is a private limited company based in Ambernath, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 03 November 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC393062.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gulam Mohiuddin Aslam Shaikh and Amit Dinesh Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F No – 06 Plot No – 34 Khaitan Bhavan, Ambernath, Maharashtra, India – 421501.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ncole Pharmaceuticals Private Limited's registered office is in Ambernath, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF No – 06 Plot No – 34 Khaitan Bhavan, Ambernath, Maharashtra, India – 421501
- IndustryPharma, API Manufacturers
To see the full contact details of Ncole Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ncole Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Ncole Pharmaceuticals Private Limited, buy the company report.
Financials of Ncole Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Ncole Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ncole Pharmaceuticals Private Limited
Ncole Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gulam Mohiuddin Aslam Shaikh Also directs: Neumedix Pharmachem LLP, Scole Pharmaceuticals Private Limited, Rivine Industries Private Limited and 2 more | Director | 03 Nov 2022 | 4 Years 0 Months | Current |
| Amit Dinesh Agarwal Also directs: Rapid Infratech LLP, Pride Buildcon & Infrastructure LLP, Mardh Viks Electrodes LLP and 4 more | Director | 03 Nov 2022 | 4 Years 0 Months | Current |
| Ramdhani Ramkishor Yadav Also directs: Neumedix Pharmachem LLP, Scole Pharmaceuticals Private Limited, Rivine Industries Private Limited and 1 more | Director | 03 Nov 2022 | 4 Years 0 Months | Current |
| Syed Azmatullah Syed Peerpasha Peerzade Also directs: Scole Pharmaceuticals Private Limited | Director | 03 Nov 2022 | 4 Years 0 Months | Current |
Auditor
Ncole Pharmaceuticals Private Limited is audited by SMITI PRABHAKAR NAYAK for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SMITI PRABHAKAR NAYAK | FY 2023 | 606443 |
Shareholding
The shareholding of Ncole Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ncole Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ncole Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ncole Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ncole Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
No GST registration is on our record for Ncole Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ncole Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Amit Dinesh Agarwal was appointed as Director on 03 Nov 2022.
Frequently asked questions
Ncole Pharmaceuticals is an active private limited company based in Ambernath, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 03 November 2022 (4+ years old) and is registered under CIN U24290MH2022PTC393062.
Ncole Pharmaceuticals has 4 current directors:
- Gulam Mohiuddin Aslam Shaikh - Director
- Amit Dinesh Agarwal - Director
- Ramdhani Ramkishor Yadav - Director
- Syed Azmatullah Syed Peerpasha Peerzade - Director
The latest financial statements of Ncole Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Ncole Pharmaceuticals is U24290MH2022PTC393062. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ncole Pharmaceuticals was incorporated on 03 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Amit Dinesh Agarwal was appointed as Director on 03 Nov 2022. Gulam Mohiuddin Aslam Shaikh was appointed as Director on 03 Nov 2022. Ramdhani Ramkishor Yadav was appointed as Director on 03 Nov 2022. Ncole Pharmaceuticals has 4 board changes on record in total.
The registered office of Ncole Pharmaceuticals is at F No – 06 Plot No – 34 Khaitan Bhavan, Ambernath, Maharashtra, India – 421501.
Ncole Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.
The compliance status of Ncole Pharmaceuticals is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.
Ncole Pharmaceuticals can be reached at its registered office: F No – 06 Plot No – 34 Khaitan Bhavan, Ambernath, Maharashtra, India – 421501.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
